GCCL

ENG

About GCCL

With an exclusive lab service available for clinical trials and a logistics system that meets global quality standards,
GCCL is building trust with over 200 partners in Asia by providing a sample analysis service spanning
the entire cycle of clinical trials to meet customer demands.

Webinar

홈   >   About GCCL   >   Newsroom   >   Webinar

Company NewsPress ReleaseGCCL ArchivesScientific ResearchWebinar

* GCCL currently doesn't offer a webinar replay service. If you have any questions or requests regarding past webinar materials,
please feel free to reach out to us at GCCL@gccorp.com or give us a call at +82) 31-270-1548.

19th GCCL Webinar - Successful Licensing Strategies : Practical Negotiation Techniques

2025. 12. 18

19th GCCL Webinar - Successful Licensing Strategies : Practical Negotiation Techniques

The first GCCL webinar of 2026 will focus on Successful Licensing Strategies : Practical Negotiation Techniques. In this 19th webinar, we will explore the purpose of licensing and recent industry trends, while sharing practical insights into strategic considerations and negotiation tactics that are critical in real-world licensing discussions. 👏 The session is designed to provide strategic perspectives and actionable decision-making criteria for professionals involved in drug development, business development (BD), and licensing functions.The webinar will be presented by KwanGoo Cho, CEO of GCCL, who brings extensive global experience in pharmaceutical R&D and business development.He holds degrees from Seoul National University College of Veterinary Medicine and the Seoul National University MBA, and has previously served as Head of the U.S. subsidiary at LG Life Sciences, Executive Vice President of Business Development at Zuellig Pharma, and CEO of Quratis. Currently, as CEO of GCCL, he oversees clinical trial sample analysis services, leveraging his deep expertise in global drug development and licensing.Topic: Successful Licensing Strategies – From Licensing Objectives and Industry Trends to Practical Negotiation TacticsDate & Time: January 21, 2026 | 2:00–3:00 PM (KST)Speaker: KwanGoo Cho, CEO, GCCL📌 Pre-registration link: https://us06web.zoom.us/webinar/register/WN_p3g4FMVSTR-cMq-__1xn8QRegistration period: Until January 19, 2026*This webinar will be held in Korean. If you're interested in sharing material, please feel free to contact us.

Read more
2025 6th GCCL Webinar - Bioanalytical Method Validation Using LC-MS/MS

2025. 10. 24

2025 6th GCCL Webinar - Bioanalytical Method Validation Using LC-MS/MS

2025 GCCL’s 6th Webinar will be held under the theme of ‘Bioanalytical Method Validation Using LC-MS/MS’. Based on the ICH M10 guideline, this webinar will cover the practical procedures and key considerations for conducting bioanalytical method validation. The speaker, Eunjin Choi, Team Manager of the Bioanalysis Team 1 at GCCL, will share practical insights drawn from her extensive experience in developing and validating LC-MS/MS-based bioanalytical methods for small molecule drugs, generics, and peptide therapeutics.- Topic : Bioanalytical Method Validation Using LC-MS/MS: Evaluation and Considerations According to Guideline - Date : November 19, 2025 (Wed) | 14:00 – 15:00 (KST)- Speaker : Eunjin Choi, Team Manager, Bioanalysis Team 1, GCCLPre-registration link : https://naver.me/5DDlzoYd  

Read more
2025 5th GCCL Webinar - FDA's Oncology Expedited Programs in Action

2025. 08. 22

2025 5th GCCL Webinar - FDA's Oncology Expedited Programs in Action

2025 5th GCCL Webinar will feature the topic ' FDA's Oncology Expedited Programs in Action - A Case-Based Approach to Strategic Drug Development ', presented by Dr. Hanlim Moon, CEO of MediRama. This webinar will be co-broadcast with the MediRama EDGE Program, focusing on FDA’s expedited programs in oncology drug development. Through real-world case studies, we will explore strategic approaches to drug development in depth. Dr. Moon, with extensive experience in oncology clinical development at global pharmaceutical companies and CROs, will deliver practical insights based on real cases.- Topic : FDA's Oncology Expedited Programs in Action - A Case-Based Approach to Strategic Drug Development  - Date & Time : September 17, 2025 (WED) 13:30 ~ 14:30 (KST) - Speaker : Dr. Hanlim Moon, CEO of MediRamaPre-registration link : https://naver.me/xwwWlyXo 

Read more
2025 4th GCCL Webinar - How to Approach Drug Development

2025. 06. 19

2025 4th GCCL Webinar - How to Approach Drug Development

GCCL's 4th Webinar of 2025 will be presented by CEO Kwan-Koo Cho under the theme “How to Approach Drug Development.” Drug development is a complex journey that requires significant time and resources. In this webinar, we will offer practical insights covering the full development cycle—from setting objectives to planning, execution, and regulatory strategies.- Topic:  How to Approach Drug Development - Date & Time: Wednesday, July 16, 2025 | 14:00 – 15:00 (KST)- Speaker: KwanKoo Cho, CEO of GCCLPre-registration link : https://naver.me/x7jopYKy

Read more
2025 3rd GCCL Webinar - Successfully Applying Clinical Trial Estimands

2025. 05. 07

2025 3rd GCCL Webinar - Successfully Applying Clinical Trial Estimands

Estimands play a vital role in designing robust clinical trials by precisely defining what needs to be estimated. As global regulatory agencies such as the FDA increasingly emphasize the Estimand Framework, understanding its practical application is becoming essential for study teams.In this webinar, leading experts from C&R Research and AJP Statistics will provide hands-on insights into how Estimands are applied in real-world clinical settings—especially in obesity and oncology trials.🎙️ Speakers🔹 Alan Phillips, Ph.D. | AJP Statistics Ltd., Statistical consultant🔹 Director Jesuk Kim | C&R Research, BS advisor🔹 Dr. Ami Yu | C&R Research, BS advisor📅 When: May 28, 2025 (Wednesday), 2:00 PM – 3:10 PM (KST)📌 How: Pre-register to receive the Zoom link via email before the event. : https://naver.me/FqW87mZH

Read more
GCCL's 5th Webinar in 2024 - SOP for GCLP

2024. 11. 06

GCCL's 5th Webinar in 2024 - SOP for GCLP

The 5th GCCL Webinar in 2024 will be led by Myungsoon Go Team Leader at GCCL, focusing on the topic of Standard Operating Procedures (SOPs) for Clinical Trial Sample Analysis Organizations (GCLP).Topic : Standard Operating Procedures (SOPs) for Clinical Trial Sample Analysis Organizations (GCLP)Date : Wednesday, September 11, 2024, 14:00-15:00Speaker : Myungsoon Go, Team Leader of GCCL QA TeamMyungsoon Go, Team Leader at GCCL, has extensive experience in QMS operations and various certifications (ISO 9001, ISO 15189, GLP, GCLP). She has served as an instructor for the Korea Society of Quality Assurance (KSQA) and currently contributes as an advisory committee member for training programs for non-clinical trial professionals. Since 2023, she has also been active as the head of the Clinical Trial Sample Division at KSQA, bringing a wealth of specialized knowledge and experience.

Read more
GCCL's 4th Webinar in 2024 - Latest Trends and Challenges in ADCs

2024. 11. 06

GCCL's 4th Webinar in 2024 - Latest Trends and Challenges in ADCs

The 4th GCCL Webinar in 2024 was conducted by Dr. Yoon-Hee Park, Principal Research Scientist at Ligachem Biosciences, focusing on the topic of the latest trends and challenges in ADCs.Topic: Latest Trends and Challenges in ADCs – ADC Development and BioanalysisDate: Wednesday, July 24, 2024, 14:00-15:00Speaker: Dr. Yoon-Hee Park, Principal Research Scientist at Ligachem BiosciencesThis webinar covered the latest trends in ADC development and bioanalysis, along with an introduction to Ligachem Bio’s ADC platform and pipeline. The discussion also included insights into bioanalysis for ADC development. Dr. Yoon-Hee Park, who led this webinar, is a project leader for technology transfer pipelines such as HER2 and ROR1-ADC and has extensive expertise in discovering various ADC drug candidates and developing pipelines.

Read more
GCCL's 3rd Webinar in 2024 - China Regulation Specifics and Consideration of Sample Management

2024. 06. 11

GCCL's 3rd Webinar in 2024 - China Regulation Specifics and Consideration of Sample Management

The third GCCL webinar in 2024 will be led by Gavin Zhang from Pharmaron on the topic of China Regulation Specifics and Consideration of Sample Management in MRCT including China.Topic: China Regulation Specifics and Consideration of Sample Management in MRCT including ChinaWhen : Thursday, May 2, 2024, 14:00-15:00Speaker : Gavin Zhang, PM Director of PharmaronThis webinar will cover regulatory and sample management considerations for MRCT(multi-regional clinical trials) including China. Gavin Zhang is currently the PM Director at Pharmaron Clinical and is a clinical professional with over 14 years of local and global clinical trial experience in various global companies (Sanofi, BI, Takeda, Pfizer and Wuxi CDS CRO).

Read more
GCCL's 2nd Webinar in 2024 - ICH M10(Bioanalytical Method Validation and Study Sample Analysis)

2024. 06. 03

GCCL's 2nd Webinar in 2024 - ICH M10(Bioanalytical Method Validation and Study Sample Analysis)

The second webinar of 2024 hosted by GCCL will be led by Kyungmin In, the head of GCCL's R&D Unit, on the topic "ICH M10 (Bioanalytical Method Validation and Study Sample Analysis)."Topic: ICH M10 - Bioanalytical Method Validation and Study Sample AnalysisDate and Time: Wednesday, March 20, 2024, 14:00~15:00Presenter: Kyungmin In, Head of R&D Unit, GCCLIn this webinar, we will cover the content of ICH M10, focusing on LBA Method, Method Validation, and Study Sample Analysis. We will explain how to interpret and implement the guidelines using Watson LIMS (7.7.1, ThermoFisher Scientific), which has been introduced for the first time in Korea.

Read more
GCCL's First Webinar in 2024 - New Drug Development Trends

2024. 06. 03

GCCL's First Webinar in 2024 - New Drug Development Trends

The first webinar of 2024 hosted by GCCL was conducted by Boyoung Jeong, Executive Director at HUMIC, on the topic "New Drug Development Trends - Immuno-Oncology Drugs and Microbiome New Drugs and Analytical Technology Trends."Topic: New Drug Development Trends - Immuno-Oncology Drugs and Microbiome New Drugs and Analytical Technology TrendsDate and Time: Wednesday, January 24, 2024, 14:00~15:00Presenter: Boyoung Jeong, Executive Director, HUMICIn this webinar, Boyoung Jeong from HUMIC covered the trends in new drug development, focusing on immuno-oncology drugs and microbiome new drugs and analytical technology trends. HUMIC is a non-clinical CRO providing efficacy evaluations for various diseases, patient-derived organoid-based technologies, and liquid biopsy analysis services using mouse models.She holds a Ph.D. from Shizuoka University in Japan and Braunschweig University of Technology in Germany. Currently, she serves as a consultant for GLG Inc and the Korea Testing Laboratory, possessing high expertise in the relevant fields.

Read more
<1>